Seeing Is Believing
Currently out of the existing stock ratings of Nathan Treybeck, 27 are a BUY (55.1%), 22 are a HOLD (44.9%).
Analyst Nathan Treybeck, currently employed at WELLS FARGO, carries an average stock price target met ratio of 69.06% that have a potential upside of 15.1% achieved within 124 days.
Nathan Treybeck’s has documented 96 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IRTC, iRhythm Technologies at 06-Oct-2026.
Analyst best performing recommendations are on NVRO (NEVRO CORP).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 8/7/2024. The price target of $5.5 was fulfilled within 1 day with a profit of $0.67 (13.87%) receiving and performance score of 138.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Jan-2026
$150
$28.73 (23.69%)
$168
21 days ago
(06-Oct-2026)
6/11 (54.55%)
$42.8 (39.93%)
337
Buy Since 06-May-2022
$194
$72.73 (59.97%)
$192
22 days ago
(05-Oct-2026)
14/20 (70%)
$84.91 (77.83%)
330
Buy Since 07-Aug-2023
$168
$46.73 (38.53%)
$160
2 months 17 days ago
(10-Aug-2026)
13/20 (65%)
$43.22 (34.64%)
195
Buy Since 06-Apr-2026
$165
$43.73 (36.06%)
$150
2 months 20 days ago
(07-Aug-2026)
2/7 (28.57%)
$37.16 (29.07%)
34
Buy Since 21-Jan-2021
$185
$66.11 (55.61%)
$185
4 months 5 days ago
(22-Jun-2026)
10/15 (66.67%)
$80.31 (76.71%)
574
Which stock is Nathan Treybeck most bullish on?
Which stock is Nathan Treybeck most reserved on?
What Year was the first public recommendation made by Nathan Treybeck?